drugset / Trial / NCT07434492
Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy
RandomizedParallel-groupTriple-blindOther
Summary
This is an intervention study to investigate the impact of a smart ankle-foot orthosis (AFO) on mobility outcomes in children with Cerebral Palsy. Participants will complete a three phase protocol including 6-weeks of at home training with the smart AFO. Participants will also have the option to participate in a randomized control trial to investigate the impact of 5-Azacitidine combined with the smart AFO to further effect mobility outcomes.
Timeline
- Start
- 2026-05-28
- Primary completion
- 2030-08-31
- Completion
- 2030-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | 75 mg/m2 | Subcutaneous |